Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | neurotensin receptor 1 (high affinity) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0037 | 0.0316 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0037 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0037 | 0.0316 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0037 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0037 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0037 | 0.0316 | 1 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0037 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.0047 | 0.1478 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0037 | 0.0316 | 0.0316 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.0532 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0047 | 0.1478 |
Giardia lamblia | GTOR | 0.0037 | 0.0316 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0193 | 0.3371 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0023 | 0.0047 | 0.1478 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0037 | 0.0316 | 0.0978 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0037 | 0.0316 | 1 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0023 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0037 | 0.0316 | 0.0316 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0186 | 0.3232 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0037 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0037 | 0.0316 | 0.0978 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0037 | 0.0316 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0037 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0047 | 0.1478 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0037 | 0.0316 | 0.0978 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1.5 nM | Binding affinity towards neurotensin receptor in membranes prepared from HT-29 cell line, relative to [111In]-labeled neurotensin peptide | ChEMBL. | 12852770 |
IC50 (binding) | = 1.5 nM | Binding affinity towards neurotensin receptor in membranes prepared from HT-29 cell line, relative to [111In]-labeled neurotensin peptide | ChEMBL. | 12852770 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.